What Is SPRAVATO and How Does It Work for Treatment-Resistant Depression?

For individuals living with depression, finding an effective treatment can sometimes be challenging. When traditional antidepressants do not provide sufficient relief, alternative treatments may be worth exploring. At Fields Psychiatric Consultants, we offer SPRAVATO® treatment to help eligible adults manage treatment-resistant depression. Understanding how this FDA-approved nasal spray works can help patients in Honolulu make informed decisions about their mental health care.

What Is SPRAVATO®?

SPRAVATO® (esketamine) is a prescription nasal spray approved by the FDA for certain forms of depression. Unlike many traditional antidepressants that primarily affect serotonin, SPRAVATO® acts on NMDA receptors involved in glutamate signaling in the brain. Its exact antidepressant mechanism is not fully understood.

Who Is SPRAVATO® Approved For?

SPRAVATO® has two FDA-approved indications:

  • Treatment-Resistant Depression (TRD): Adults who have not experienced sufficient improvement after trying at least two appropriate antidepressant treatments may qualify. SPRAVATO® can be prescribed alone or alongside an oral antidepressant.
  • Major Depressive Disorder (MDD) With Acute Suicidal Ideation or Behavior: SPRAVATO® is also approved, in combination with an oral antidepressant, to treat depressive symptoms in adults experiencing acute suicidal thoughts or behavior.

Importantly, SPRAVATO® has not been demonstrated to prevent suicide or reduce suicidal behavior. It does not replace emergency psychiatric intervention or hospitalization when necessary.

How Does the SPRAVATO® Treatment Process Work?

At Fields Psychiatric Consultants, we help patients understand their treatment options and determine whether SPRAVATO® may be appropriate. The treatment process generally involves:

  • Initial Evaluation: We review your depression history, previous medications, current symptoms, and overall health to assess eligibility.
  • Treatment Preparation: Patients are advised to avoid food for at least two hours and liquids for at least 30 minutes before treatment.
  • Nasal Spray Administration: Patients self-administer SPRAVATO® under direct medical supervision in a healthcare setting certified in the SPRAVATO® REMS program. Outpatients must also enroll in that program.
  • Medical Monitoring: Following administration, patients remain under observation for at least two hours while blood pressure, breathing, and potential side effects are monitored.
  • Transportation Home: Patients must arrange transportation and avoid driving until the following day after a restful night's sleep.

How Often Are SPRAVATO® Treatments Needed?

For treatment-resistant depression, the usual schedule begins with twice-weekly sessions for four weeks. Treatments typically decrease to once weekly during weeks five through eight, followed by weekly or every-other-week maintenance sessions based on individual response. Our team discusses the appropriate treatment plan during your evaluation.

Are There Side Effects?

SPRAVATO® can cause dizziness, nausea, sedation, dissociation, and temporary increases in blood pressure. Serious risks include respiratory depression and potential misuse. Antidepressants may increase suicidal thoughts or actions in some people age 24 and younger, especially early in treatment or when doses change. Report new or worsening symptoms to your clinician right away; seek emergency help for immediate danger.

Not everyone is a suitable candidate, particularly individuals with certain vascular conditions or a history of bleeding in the brain. We carefully evaluate medical history and potential risks before recommending treatment.

Explore SPRAVATO® Treatment Across Hawaii

If traditional antidepressants have not provided sufficient relief, Fields Psychiatric Consultants can help you explore whether SPRAVATO® is right for you. Contact our team to schedule a consultation and confirm treatment availability at our locations: Mililani Tech Park at (808) 207-9800, Chinatown in Honolulu at (808) 207-9800, Wailuku at (808) 207-9800, Hawaii Kai at (808) 207-9800, Lihue at (808) 207-9800, or Mililani Town Center at (808) 207-9800.